BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/14/2025 12:56:24 AM | Browse: 39 | Download: 216
 |
Received |
|
2025-08-07 02:24 |
|
Peer-Review Started |
|
2025-08-07 02:24 |
|
First Decision by Editorial Office Director |
|
2025-09-04 10:39 |
|
Return for Revision |
|
2025-09-06 08:41 |
|
Revised |
|
2025-09-19 15:02 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-10-27 02:36 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-10-27 07:12 |
|
Articles in Press |
|
2025-10-27 07:12 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-11-05 00:45 |
|
Publish the Manuscript Online |
|
2025-11-14 00:56 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, Research & Experimental |
| Manuscript Type |
Basic Study |
| Article Title |
RSPO3 rearrangements in advanced colorectal cancer patients and their relationship with disease characteristics
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Raquel Tur, Mar Abad, Elena Filipovich, Maria Belen Rivas, Marta Rodriguez, Juan Carlos Montero and José María Sayagués |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
José María Sayagués, Senior Scientist, Department of Pathology-University Hospital of Salamanca, Institute of Biomedical Research of Salamanca, Paseo de San Vicente, 58-182, Salamanca 37007, Spain. ppmari@usal.es |
| Key Words |
Advanced colorectal cancer; Next-generation sequencing; Protein tyrosine phosphatase receptor type k::R-spondin 3 fusion; Wnt signaling; Genomic alterations |
| Core Tip |
In our study, we identified key genomic alterations in advanced colorectal cancer using next-generation sequencing. The most frequent mutations occurred in tumor protein p53, Kirsten rat sarcoma viral oncogene homolog, phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha, B-Raf kinase, and fibroblast growth factor receptor 3, with distinct mutational patterns observed between tumors originating in the left and right colon. Notably, protein tyrosine phosphatase receptor type k::R-spondin 3 fusion were detected in 8% of cases, predominantly in right-sided tumors, and were associated with poorer overall survival, supporting their relevance as both a biomarker and therapeutic target. Larger prospective studies are needed to confirm their clinical utility in colorectal cancer. |
| Publish Date |
2025-11-14 00:56 |
| Citation |
Tur R, Abad M, Filipovich E, Rivas MB, Rodriguez M, Montero JC, Sayagués JM. RSPO3 rearrangements in advanced colorectal cancer patients and their relationship with disease characteristics. World J Gastrointest Oncol 2025; 17(11): 112838 |
| URL |
https://www.wjgnet.com/1948-5204/full/v17/i11/112838.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v17.i11.112838 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
